Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana C Valencia-Olvera

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Alzheimer'S Research & Therapy|February 1, 2026
Proof-of-concept study: APOE4 brain endothelial cells as a phenotypic compound screenAna C Valencia-Olvera, Felecia M Marottoli, Kiira Ratia, et al.
Journal of Neuroendocrinology|November 24, 2022
Role of estrogen in women's Alzheimer's disease risk as modified by APOEAna C Valencia-Olvera, Juan Maldonado Weng, Amy Christensen, et al.
Current Topics in Medicinal Chemistry|June 21, 2016
Rexinoids as Therapeutics for Alzheimer's Disease: Role of APOEKevin P Koster, Conor Smith, Ana C Valencia-Olvera, et al.
Alzheimer'S Research & Therapy|October 20, 2023
A small-molecule TLR4 antagonist reduced neuroinflammation in female E4FAD miceDeebika Balu, Ana C Valencia-Olvera, Austin Nguyen, et al.
Journal of Alzheimer'S Disease : JAD|February 2, 2024
APOE2 Heterozygosity Reduces Hippocampal Soluble Amyloid-β42 Levels in Non-Hyperlipidemic MiceAna C Valencia-Olvera, Deebika Balu, Annabelle Moore, et al.
Frontiers in Aging Neuroscience|November 29, 2023
<i>APOE</i> genotype and sex modulate Alzheimer's disease pathology in aged EFAD transgenic miceDeebika Balu, Ana C Valencia-Olvera, Zarak Islam, et al.
Alzheimer'S Research & Therapy|December 16, 2023
A novel apoE-mimetic increases brain apoE levels, reduces Aβ pathology and improves memory when treated before onset of pathology in male mice that express APOE3Ana C Valencia-Olvera, Deebika Balu, Shreya Bellur, et al.
Frontiers in Endocrinology|May 14, 2024
Estradiol improves behavior in FAD transgenic mice that express <i>APOE3</i> but not <i>APOE4</i> after ovariectomyDeebika Balu, Ana C Valencia-Olvera, Ashwini Deshpande, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|May 8, 2023
Inhibition of ACAT as a Therapeutic Target for Alzheimer's Disease Is Independent of ApoE4 LipidationAna C Valencia-Olvera, Deebika Balu, Naomi Faulk, et al.
Journal of Medicinal Chemistry|August 27, 2024
Nonlipogenic ABCA1 Inducers (NLAI) for Alzheimer's Disease Validated in a Mouse Model Expressing Human <i>APOE3/APOE4</i>Ganga Reddy Velma, Megan S Laham, Cutler Lewandowski, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Alzheimer'S Research & Therapy|February 1, 2026
Proof-of-concept study: APOE4 brain endothelial cells as a phenotypic compound screenAna C Valencia-Olvera, Felecia M Marottoli, Kiira Ratia, et al.
Journal of Neuroendocrinology|November 24, 2022
Role of estrogen in women's Alzheimer's disease risk as modified by APOEAna C Valencia-Olvera, Juan Maldonado Weng, Amy Christensen, et al.
Current Topics in Medicinal Chemistry|June 21, 2016
Rexinoids as Therapeutics for Alzheimer's Disease: Role of APOEKevin P Koster, Conor Smith, Ana C Valencia-Olvera, et al.
Alzheimer'S Research & Therapy|October 20, 2023
A small-molecule TLR4 antagonist reduced neuroinflammation in female E4FAD miceDeebika Balu, Ana C Valencia-Olvera, Austin Nguyen, et al.
Journal of Alzheimer'S Disease : JAD|February 2, 2024
APOE2 Heterozygosity Reduces Hippocampal Soluble Amyloid-β42 Levels in Non-Hyperlipidemic MiceAna C Valencia-Olvera, Deebika Balu, Annabelle Moore, et al.
Frontiers in Aging Neuroscience|November 29, 2023
<i>APOE</i> genotype and sex modulate Alzheimer's disease pathology in aged EFAD transgenic miceDeebika Balu, Ana C Valencia-Olvera, Zarak Islam, et al.
Alzheimer'S Research & Therapy|December 16, 2023
A novel apoE-mimetic increases brain apoE levels, reduces Aβ pathology and improves memory when treated before onset of pathology in male mice that express APOE3Ana C Valencia-Olvera, Deebika Balu, Shreya Bellur, et al.
Frontiers in Endocrinology|May 14, 2024
Estradiol improves behavior in FAD transgenic mice that express <i>APOE3</i> but not <i>APOE4</i> after ovariectomyDeebika Balu, Ana C Valencia-Olvera, Ashwini Deshpande, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|May 8, 2023
Inhibition of ACAT as a Therapeutic Target for Alzheimer's Disease Is Independent of ApoE4 LipidationAna C Valencia-Olvera, Deebika Balu, Naomi Faulk, et al.
Journal of Medicinal Chemistry|August 27, 2024
Nonlipogenic ABCA1 Inducers (NLAI) for Alzheimer's Disease Validated in a Mouse Model Expressing Human <i>APOE3/APOE4</i>Ganga Reddy Velma, Megan S Laham, Cutler Lewandowski, et al.
Pageof 1